GLS and nonpapillary renal cell carcinoma: As we have seen above, eosinophilic cells are enriched in lymphocytic inflammatory infiltrate and mitochondria, so we would expect immunotherapies combined with glutaminase inhibitors to be beneficial in eosinophilic rather than clear cells ccRCC in future clinical trials.